Development of cannabinoids

At Recipharm, we have the experience and appropriate licencing to support both development and commercial supply of cannabinoids. And, to further assist researchers and pharma companies working in this field, we have also developed new, synthetic routes to five different cannabinoids, including CBDA, CBGA, and three metabolites. In addition, we have identified a novel, scalable, synthetic route to CBD.

Learn more about our capabilities by downloading our fact sheet below.

 

/sites/default/files/media/Development%20of%20cannabinoids_0.pdf
False
False